Skip to main content
IBRXHealthcare

ImmunityBio Inc (IBRX) Insider Trading

In the last 90 days, 2 ImmunityBio Inc (IBRX) insiders reported no open-market purchases and 2 sales totaling $1,119,848. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 5, 2026Barry J. SimonCorporate insiderSale25,000$10.75$268,760
Oct 2, 2026Cheryl CohenCorporate insiderSale81,056$10.50$851,088
Jul 2, 2026Cheryl CohenCorporate insiderSale131,210$9.50$1,246,941
Jul 1, 2026Christobel SeleckyCorporate insiderSale159,478$9.02$1,439,066
Jun 30, 2026Christobel SeleckyCorporate insiderSale96,722$9.01$871,214
Jun 24, 2026Barry J. SimonCorporate insiderSale25,000$7.88$196,908
Jun 4, 2026Barry J. SimonCorporate insiderSale23,033$7.18$165,306

Common questions

IBRX insider trading FAQ

Are IBRX insiders buying or selling?
Over the last 90 days, IBRX insiders were net sellers, reporting $0.00 of open-market purchases and $1,119,848 of sales.
When was the last IBRX insider purchase?
No open-market insider purchase of ImmunityBio Inc stock was reported in the last 90 days.
Where does IBRX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that ImmunityBio Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.